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ABSTRACT
One of the very complex structures in the vertebrates is the joint. The main component of the joint is the synovial fluid with its high-
molar-mass glycosaminoglycan hyaluronan, which turnover is approximately twelve hours. Since the synovial fluid does not contain 
any hyaluronidases, the fast hyaluronan catabolism is caused primarily by reductive-oxidative processes. 
Eight transition metals – V23, Mn25, Fe26, Co27, Ni28, Cu29, Zn30, and Mo42 – naturally occurring in living organism are essential for the 
control of various metabolic and signaling pathways. They are also the key elements in catabolism of hyaluronan in the joint.
In this overview, the role of these metals in physiological and pathophysiological catabolism of hyaluronan is described. The participa-
tion of these metals in the initiation and propagation of the radical degradation hyaluronan is critically reviewed. 
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Transition metals
Thirty eight chemical elements, with the atomic numbers 
21 to 30, 39 to 48, 72 to 80, and 104 to 112, are termed 
transition metals (cf. Table 1). Of these the following eight – 
vanadium, manganese, iron, cobalt, nickel, copper, zinc, and 
molybdenum – belong to the biogenic trace elements. Thus 
V23, Mn25, Fe26, Co27, Ni28, Cu29, Zn30, and Mo42 could be 
classified as “biogenic transition metals”.
In most cases, the valence electrons of the transition 
metal, i.e. those electrons used in formation of the bonds 
with other elements, are present in two outermost orbitals. 
For this reason, transition metals may exist in several oxida-
tion states (characterized by the oxidation numbers). For the 
biogenic transition metals, these states/numbers are listed 
in Table 2.
Transition metals may form complexes with both 
charged and neutral ligands. A variety of different oxidation 
states as well as the coordination by ligands provide redox 
and/or catalytic activity to transition metals, which serve as 
the catalytic centers of enzymes (oxidases, dehydrogenases).
Biogenic elements 
Virtually each of the chemical elements plays some role 
in the Earth’s living systems, however, only 24 elements 
account for the vast majority of material in these systems. 
These elements are divided into (i) six major biogenic ele-
ments, namely carbon, hydrogen, oxygen, nitrogen, sulfur, 
and phosphorus, (ii) five minor biogenic elements, sodium, 
potassium, magnesium, calcium, and chlorine, and (iii) 
thirteen biogenic trace elements comprising manganese, 
iron, cobalt, copper, zinc, boron, aluminum, vanadium, 
molybdenum, iodine, silicon, nickel, and bromine. 
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Most biogenic transition metals participate in the con-
trol of various metabolic and signaling pathways. However, 
their versatile coordination chemistry and redox properties 
allow them to escape the control mechanisms, such as 
homeostasis, transport, compartmentalization, and binding 
to the designated tissue and cell constituents (Valko et al., 
2005).
When these metals are liberated from their catalytic 
sites within enzymes and sequestered abnormally by 
other ligands, the consequences can be deleterious for the 
environment. Under such circumstances, irreversible oxi-
dative changes to both the metal-complexing ligand itself 
and the neighboring molecules that intercept the reactive 
intermediates of the initial reaction, may initiate a cascade 
of oxidative stress events (HaMai et al., 2001). 
Moreover, transition metal ions have a specific feature, 
the so-called “isoelectronics”. The manganeous ions are 
electronically equivalent to the ferric ones, both having five 
electrons (d5 configuration) in the valence subshells, which 
predetermine their mutual substitutability, e.g. in the octa-
hedral coordination complexes. A similar isoelectronics, 
within tetrahedral coordination complexes, can be found for 
Zn(II) and Cu(I), i.e. both possess d10 configuration, or for a 
less common pair Fe(II) and Co(III) – the d6 configuration 
of the valence electrons. Such an isoelectronic effect may 
allow ions of two different elemental species to compete for 
the same ligands.
Coordination of iron with biomolecules involves the 
participation of its d orbitals. Since molecular oxygen using 
its electrons in antibonding π* orbitals can ligate to iron by 
overlapping its d orbitals, iron may serve as a bridge between 
the biomolecule and oxygen. The “flexibility” of iron not 
only means its ability to vary the oxidation state, but also 
implies its capacity to change electronic spin properties 
and relative redox potential in response to interaction with 
different coordinating ligands. When ascorbate is the coor-
dinating biomolecule/ligand, it acts as both the iron chelator 
and reductant. Hence ascorbate upon binding with Fe(III) 
reduces iron to the Fe(II) ion, which forms a coordination 
complex ascorbate-Fe(II)-oxygen (Valko et al., 2005). This 
so-called Udenfriend’s oxidative complex/system is a very 
efficient reagent, used by organic chemists, to hydroxylate 
aromatic compounds, saturate hydrocarbons to alcohols, 
olefins to epoxides, etc. (Udenfriend et al., 1954). With cop-
per, the so-called Weissberger’s system – ascorbate-Cu(I)-
oxygen (Weissberger et al., 1943; Khan and Martell, 1967) 
– may generate hydrogen peroxide (cf. Scheme 1) (Fisher 
and Naughton, 2003; 2004; 2005). Due to H2O2 decomposi-
tion through Fenton-like reaction, the Weissberger’s system 
belongs to the most efficient generators of hydroxyl radicals 
(Šoltés et al., 2006).
In the case when Udenfriend’s or Weissberger’s systems 
do not have additional oxidizable substrate, one speaks of 
“ascorbate auto-oxidation” (Buettner and Jurkiewicz, 1993), 
where the resulting reaction product is dehydroascorbate 
(DHA). However, in the simultaneous presence of oxidizable 
substrates, the reaction products comprise both oxidized/
decomposed substrates (Šoltés et al., 2007).
Vanadium
The oxidation states of vanadium include +5, +2, +3, and 
+4; that of + 1 is rarely observed (T able 2). Vanadium is 
an essential element of some enzymes (e.g. nitrogenases 
in nitrogen-fixing micro-organisms). Rats and chickens 
are known to require vanadium; deficiency in vanadium 
results in their reduced growth and impaired reproduction. 
Table 1. Transition metals.
Group 3 (III B) 4 (IV B) 5 (V B) 6 (VI B) 7 (VII B) 8 (VIII B) 9 (VIII B) 10 (VIII B) 11 (I B) 12 (II B)
Period 4 Sc 
21 Ti 
22 V 
23 Cr 
24 Mn 
25 Fe 
26 Co 
27 Ni 
28 Cu 
29 Zn 
30
2, 8
9, 2
2, 8
10, 2
2, 8
11, 2
2, 8
13, 1
2, 8
13, 2
2, 8
14, 2
2, 8
15, 2
2, 8
16, 2
2, 8
18, 1
2, 8
18, 2
Period 5 Y 
39 Zr 
40 Nb 
41 Mo 
42 Tc 
43 Ru 
44 Rh 
45 Pd 
46 Ag 
47 Cd 
48
2, 8, 18
9, 2
2, 8, 18
10, 2
2, 8, 18
12, 1
2, 8, 18
13, 1
2, 8, 18
14, 1
2, 8, 18
15, 1
2, 8, 18
16, 1
2, 8, 18
18, 0
2, 8, 18
18, 1
2, 8, 18
18, 2
Period 6 * Hf 
72 Ta 
73 W 
74 Re 
75 Os 
76 Ir 
77 Pt 
78 Au 
79 Hg 
80
2, 8, 18, 32
10, 2
2, 8, 18, 32
11, 2
2, 8, 18, 32
12, 2
2, 8, 18, 32
13, 2
2, 8, 18, 32
14, 2
2, 8, 18, 32
15, 2
2, 8, 18, 32
17, 1
2, 8, 18, 32
18, 1
2, 8, 18, 32
18, 2
Period 7 ** Rf 
104 Db 
105 Sg 
106 Bh 
107 Hs 
108 Mt 
109 Ds 
110 Rg 
111 Uub 
112
2, 8, 18, 32, 32
10, 2
2, 8, 18, 32, 32
11, 2
2, 8, 18, 32, 32
12, 2
2, 8, 18, 32, 32
13, 2
2, 8, 18, 32, 32
14, 2
2, 8, 18, 32, 32
15, 2
2, 8, 18, 32, 32
17, 1
2, 8, 18, 32, 32
18, 1
2, 8, 18, 32, 32
18, 2
* La – lanthanide series; ** Ac – actinide series
The transition metals (in shaded boxes) – vanadium, manganese, iron, cobalt, nickel, copper, zinc, and molybdenum – belong to biogenic trace ele-
ments. The numbers in the first line under the element symbol represent number of electrons in the innermost (closest to the nucleus) orbitals, while 
those in the second line correspond to the electrons in the valence/binding orbitals.231
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Administration of oxovanadium compounds was shown to 
alleviate Diabetes mellitus manifestations in certain animal 
models and humans.
Manganese
Th  e common oxidation states/numbers of manganese are 
+2, +3, +4, +6, and +7, although oxidation states +1 and +5 
have also been observed (Table 2). Compounds, in which 
manganese exists in higher oxidation states are powerful 
oxidizing agents. Potassium permanganate (oxidation 
number +7) is used in medicine as an efficient disinfectant. 
Mn(III)-acetate is a relatively powerful oxidizing agent; 
the Mn(III)/Mn(II) standard reduction potential E’° equals 
+1.5 V.
Manganese ions function as cofactors for a number of 
enzymes, of which Mn-containing superoxide dismutase 
(Mn-SOD) is one of the most essential enzymes required for 
almost all organisms living in the presence of oxygen. They 
use Mn-SOD to deal with the toxic effects of superoxide 
anion radicals (O2
•–), formed by the one-electron reduc-
tion of dioxygen. Exceptions include Lactobacilli bacteria, 
which for the task of O2
•– detoxification use a different non-
enzymatic mechanism involving Mn(II) complexed directly 
with polyphosphate. Further classes of enzymes, which 
may have manganese “cofactors”, include oxidoreductases, 
transferases, hydrolases, lyases, isomerases, and ligases.
The human body contains about 300 ppm of manganese; 
the recommended daily intake of this essential element 
is 3–9 mg (Roth, 2006). The low manganese turnover 
observed in patients with rheumatoid arthritis may cause 
disturbances in the synthesis of mucopolysaccharides 
observed in experimental animals with man  ganese defi-
ciency (Niedermeier and Griggs, 1971). A heavy exposure 
to manganese can, however, cause chronic manganism – a 
form of Parkinson’s disease. 
Manganous ions are paramagnetic and hence they are 
detectable by EPR spectroscopy. Six-band EPR spectrum of 
Mn(II) has been detected in most natural products. 
Iron
The Fe(III) /Fe(II) reduction potential at pH 7 equaling +0.48 
V (Koppenol, 1994) predetermines iron as one of the major 
candidates in the production (and metabolism) of free 
radicals in biological systems. Contrary to ferric salts, which 
at neutral pH precipitate forming oxyhydroxide aggregates, 
ferrous compounds are soluble, though unstable, since they 
tend to react with dioxygen yielding O2
•– and Fe(III). 
In mammals, the iron distribution is heavily regulated 
because Fe(II) ions represent a risk/toxic factor. Excessive 
iron intake can result in iron overload disorders, such as 
hemochromatosis, while diminished absorption of this 
essential biogenic element from the duodenum or deficit of 
this metal in food may lead to anemia.
The average-weight human body contains approximately 
4–5 g of iron firmly bound/complexed in metalloproteins 
such as the oxygen carrier – hemoglobin, the enzymes con-
taining heme prosthetic groups – catalase, cytochromes, 
Table 2. Oxidation states (oxidation numbers) of the biogenic transition 
metals.
Element
Oxidation states/
numbers
Electronegativity
(Pauling scale)
Ionization energies: 
1st; 2nd; 3rd [kJ/mol]
Vanadium Va II, III, IV (I)b 1.63 650.9; 1414; 2830
Manganese II III, IV, VI, VII, (I, V) 1.55 717.3; 1509; 3248
Iron III II, V, (IV, VI) 1.83 762.5; 1561.9; 2957
Cobalt II III, (IV) 1.88 760.4; 1648; 3232
Nickel II III, (I, IV) 1.91 737.1; 1753; 3395
Copper II I, (III, IV) 1.90 745.5; 1957.9; 3555
Zinc II 1.65 906.4; 1733.3; 3833
Molybdenum VI II, III, IV, V 2.16 684.3; 1560; 2618
a,b The most (2nd column) and the less (3rd column) common oxidation 
states/numbers. 
b Rare oxidation states/numbers are given in parentheses.
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Scheme 1. Generation of H2O2 by Weissberger’s system from ascorbate and Cu(II) under aerobic condi-
tions (adapted from Fisher and Naughton, 2005).232
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and in the iron transport/storage proteins – transferrin, 
ferritin, and hemosiderin.
Transferrin, a glycoprotein, has two separate binding 
sites to which Fe(III) attaches extremely tightly. Under 
physiological conditions, the transport protein – transfer-
rin – present in the bloodstream is, however, loaded only to 
ca. 30% of its total iron-binding capacity, so that the amount 
of “free” iron salts available in plasma should be negligible.
Ferritin is a high-capacity and low-affinity storage pro-
tein with the capacity of about 4,500 atoms of iron per one 
protein macromolecule. Iron from ferritin can be removed 
by the action of some “bioreductants”, such as ascorbate. 
However, in tissues only trace amounts of iron are thought 
to remain “free” (non-chelated) or loosely chelated. Evidence 
was provided that iron may be present in tissues in the 
micromolar range complexed/bound to atp, amp, gtp, 
and possibly citrate (Koppenol, 1994).
Cobalt
Cobalt is essential to humans. This metal ion is the central 
component of cobalamin (Vitamin B12).
Nickel
The most common oxidation state of nickel is +2, although 
in Ni-complexes oxidation states +1, +3, and +4 have also 
been observed. Solubilized Ni(II) ions in aqueous media at 
physiological pH are hydrated to a hexahydrate [Ni(H2O)6]2+ 
cation. 
The main Ni-transporting protein in blood is albumin, 
though nickeloplasmin also transports these metal ions. The 
role of nickel in enzymes such as urease, glyoxalase, and a 
class of superoxide dismutase has recently been recognized 
(Thornalley, 2003; Szilagyi et al., 2004).
The daily intake of nickel is estimated to be in the range 
35–300 μg.
Copper
An average adult human body contains about 80 mg of cop-
per; the recommended copper intake for adults is 0.9 mg/day. 
When copper is first absorbed in the gut, it is transported to 
the liver tightly bound to albumin. 
Copper is stored in hepatocytes bound to metallothio-
nein. In the bloodstream, copper is bound/carried within 
a plasma protein – ceruloplasmin. Each ceruloplasmin 
macromolecule, which molar mass is around 134 kDa, 
complexes/binds up to eight copper ions, of which two can 
liberate relatively easily (Shukla et al., 2006). Redox-active 
copper is the principal constituent in a variety of enzymes, 
including cytochrome c oxidase and CuZn-superoxide 
dismutase (CuZn-SOD).
Copper toxicity is derived from its ability to accept and 
donate single electrons. It has been claimed that cuprous/
cupric ions catalyze the production of hydroxyl radical in 
a manner analogous to Fenton chemistry. This increase in 
unmediated reactive radicals, generally termed oxidative 
stress, is an active area of research in a variety of diseases 
where copper may play an insidious role.
In high amounts, copper can be poisonous and even 
fatal to organisms. This metal has been implica  ted in 
the pathogenesis of neurodegenerative disorders, such as 
Alzheimer’s and Parkinson’s diseases, as well as amyotrophic 
lateral sclerosis. In Wilson’s disease, body tissues, mostly the 
liver and brain, retain too much copper. d-Penicillamine and 
oral Zn-supplements have been used for treating patients 
with Wilson’s disease (Gaetke and Chow, 2003).
Zinc
Zin c  is  a  c o m p o n e n t  o f  m a  n y  m e tall o p r o t e ins  s u c h  as  
metalloenzymes and metallothionein proteins. Chelatable 
redox-inert Zn(II) may serve as an antioxidant by preventing 
binding of pro-oxidant cuprous ions at tissue sites.
The adult human body contains approximately 1.5–2.5 g 
of zinc. The recommended dietary allowance of zinc is 11 
mg for males and 8  mg for females, with higher amounts 
recommended during pregnancy and lactation. Brain 
development is stunted by zinc insufficiency in utero and 
in youth.
Zinc is excreted mostly in feces ( 12– 15 mg/ day) and 
lesser amounts (0.5 mg/day) are eliminated in urine.
Molybdenum
Molybdenum is present in several enzymes such as 
aldehyde and sulfite oxidases. The purine catabolism, 
involving the oxidation of xanthine to uric acid, is catalyzed 
by xanthine oxidase – a Mo-containing enzyme.
A 70-kg human body contains about 10 mg of molybde-
num, which occurs in higher concentrations in the liver and 
kidneys. The optimal daily intake of molybdenum is 0.3 mg. 
Molybdenum deficiency may cause growth retardation and 
impaired reproduction. High amounts of molybdenum can 
interfere with the body’s uptake of copper.
Non-enzymatic peroxidation – 
a radical chain reaction
As can be concluded from the above facts, biogenic transi-
tion-metal ions are sequestered by proteins: iron in transfer-
rin and ferritin, copper in ceruloplasmin, etc. However, a 
small amount of low-molar-mass metal chelates/complexes 
is likely to be present at all times due to the transfer of 
metals from storage proteins to metalloproteins and the 
turnover of these proteins (Koppenol, 1994; Halliwell and 
Gutteridge, 1990). 
Metal ions – especially those of iron – are capable of 
redox cycling by accepting [Fe(III) + 1e– → Fe(II)] or donat-
ing [Fe(II) – 1e– → Fe(III)] electron(s). These capabilities 
are closely related with the catalytic participation of iron in 
reactions producing oxygen-derived reactive species. 
In a wide variety of in vitro systems, Fe(II) salts and/or 
non-enzyme chelated/complexed ferrous cations (e.g. Fe(II)-
EDTA) were shown to enhance radical damage by increas-
ing the production of oxygen-derived reactive species. 
Initiation reaction(s)
In a completely peroxide-free system, the initia  tion of a 
peroxidation sequence refers to the attack of any species 
that has sufficient reactivity to abstract a hydrogen atom (H• 233
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radical) from the (bio)substrate involved in a radical chain 
reaction. O2
•– is insufficiently reactive to abstract the H• 
radical. The protonated form of O2
•–, i.e. HO2
•, although 
present in a trace amount, is more reactive and appears 
to be capable of abstracting the H• radical (Halliwell and 
Gutteridge, 1990). Alternatively, complexes of Fe(II) ions 
and dioxygen are also assumed to yield reactive species of 
unknown nature, which are subsequently able to oxidize 
biological material (Qian and Buettner, 1999; Flemmig and 
Arnhold, 2007). However, as generally believed, the most 
efficient acceptor of a H• radical should be the hydroxyl free 
radical – •OH, which redox potential (•OH/H2O) equals 
+2.31 V at pH 7. For generation of •OH radical(s), a sequence 
of the following reactions has been usually suggested
2Fe(II) + 2O2 ↔ 2Fe(III) + 2O2
•– (redox reaction; reversible)  (i)
2O2
•– + 2H+ → H2O2 + O2 (dismutation reaction)  (ii)
----------------------------------------------
2Fe(II) + O2 + 2H+ → 2Fe(III) + H2O2  net reaction
_______________________________
Fe(II) + H2O2 → Fe(III) + •OH + HO– (Fenton reaction)  (1)
O2
•– + H2O2 ↔ HO• + HO– + O2 (Haber-Weiss reaction; reversible)  (2)
(It is, however, important to note that high Fe(II) con-
centration can diminish the overall yield of •OH radicals by 
scavenging them [•OH + Fe(II) → Fe(III) + HO–].)
As evident, both reactions 1 and 2 yield •OH radicals, 
which may initiate e.g. peroxidation of (polyunsaturated) 
fatty acids in lipids (LH) and thus generate peroxyl lipid 
radicals (LOO•) by a sequence of the following reactions
LH + •OH → L• + H2O  (3)
L• + O2 → LOO•  (4)
Propagation reaction(s)
The LOO• radicals propagate the lipid peroxidation chain 
reactions as follows
LOO• + LH → LOOH + L•   (5)
and the reaction 5 is then followed by reaction 4.
It should be pointed out that if a sufficiently high excess 
of ferrous cations is still present in the system, the produced 
lipid hydroperoxides (may) undergo an iron(II)-driven 
“decomposition” reaction
 
LOOH + Fe(II) → LO• + HO– + Fe(III)   (6)
yielding an alkoxyl lipid radical (LO•), which, due to its 
qualitatively similar reactivity as that of the lipid peroxyl 
radical (LOO•), may propagate the lipid peroxidation as 
follows
LO• + LH → LOH + L•   (7)
and the reaction 7 is then also followed by reaction 4.
It has to be admitted that kinetically the reaction of 
Fe(II) with lipid hydroperoxides (reaction 6) is very plausible 
to occur since it is by one order of magnitude faster than the 
Fe(II)-mediated reaction of H2O2 decomposition (the rate 
constant for reaction 1 (and reaction 2 as well) is about 76 
M–1 s–1, while for reaction 6 the constant is equal to ca. 
103 M–1 s–1; Halliwell and Gutteridge, 1990).
To elucidate the frequently observed fact that the in 
vitro lipid peroxidation can be initiated also by ferric salts/
complexes, it should be taken into account that during stor-
age and handling under oxygen-containing atmosphere, all 
commercially available lipids are readily oxidized, yielding a 
“contaminant” – LOOH. And this is exactly the substance, 
which acts as an initiator of the (in vitro) lipid peroxidation 
due to the reaction 
LOOH + Fe(III) → LOO• + Fe(II) + H+   (8) 
that is subsequently followed by reaction 5.
An important fact should be noted, namely that due to 
a high tendency of ferrous ions to be oxidized (the Fe(III)/
Fe(II) reduction potential is equal to +0.48 V at pH  7 
(Koppenol, 1994)), practically none of the Fe(II) salts/com-
plexes is free of Fe(III) cations. Although Fe(III) should not 
trigger lipid peroxidation, due to ubiquitous contamination 
of lipids with the hydroperoxides LOOH, addition of Fe(III) 
initiates a radical chain reaction since its reaction with 
hydroperoxides generates LOO• radicals according to the 
reaction 8.
If the potential of the Fenton reaction to take place is not 
unambiguously confirmed, one can come to a false conclu-
sion that upon reacting with hydrogen peroxide any (bio-
genic) transition metal in lower oxidation state (Mn+) would 
generate hydroxyl radicals by the reaction Mn+ + H2O2 → 
M(n+1) + •OH + HO–. However, most researchers agree with 
the statement that under normal/physiological conditions in 
vivo only the iron(II)-dependent formation of •OH radicals 
may actually occur (Halliwell and Gutteridge, 1990). 
Joint – role of hyaluronan
A joint is formed by the ends of two (or more) bones con-
nected by connective tissues. The function of joints in the 
human organism is to ensure mutual motion of the adjacent 
bones in plane (bending x ↔ y) as well as in space (rotation 
x ↔ y ↔ z). The bone ends linked in a joint are covered 
with a thin soft layer – the cartilage, which matrix is 
being permanently restructured/rebuilt by the embedded 
chondrocytes. 
Every joint is surrounded by a fibrous tissue capsule 
called synovium. The primary function of synovium is the 
production of synovial fluid (SF), which reduces friction and 
wear and tear of the joint. The main components of this 
“lubricating” fluid are a filtrate of blood plasma and a high-
molar-mass polysaccharide – hyaluronan (HA), extruded by 
the type II synoviocytes, the cells localized within synovial 
membrane.
HA (Figure 1) is a linear high-molar-mass natural 
polysaccharide formed from disaccharide units containing 
N-acetyl-d-glucosamine and d-glucuronic acid. The chemi-
cal structure of HA is rather regular, the only deviation 234
L. Šoltés and G. Kogan
Catabolism of hyaluronan: involvement of transition metals
ISSN: 1337-6853 (print version) | 1337-9569 (electronic version)
being a possible replacement of N-acetyl-d-glucosamine by 
deacetylated glucosamine residues. In an aqueous milieu, 
HA is represented by negatively charged hyaluronate macro-
molecules with extended conformations, which impart high 
viscosity/viscoelasticity to its solution (Hardingham, 2004). 
In human beings, HA is abundantly present in almost 
all body fluids and tissues. In synovial fluid and vitreous 
humor, HA macromolecules reaching megadalton molar 
masses, are present in a “free form”, i.e. not associated with 
proteins. In the articular cartilage matrix, however, HA is 
associated via a link protein with a proteoglycan – aggrecan 
– consisting of collagen and glycosaminoglycans, namely 
chondroitin sulfate and keratan sulfate.
In a healthy human being, the synovial fluid containing 
along with the blood plasma filtrate also the entangled mac-
romolecules of HA (1.4–3.6 mg/mL; Kogan et al., 2007), rep-
resents a gel-like colloidal medium. The nutrients, including 
oxygen supply, upon crossing the synovial barrier permeate 
through the viscous colloid to the avascular articular car-
tilage where they are utilized by embedded chondrocytes. 
On the other hand, the chondrocyte catabolites (should) 
cross both the viscous fluid and synovial membrane. It can 
thus be concluded that within the articular gel-like fluid, the 
process of “mixing” at the increased mobility of the joint, 
may significantly affect joint homeostasis.
Hypoxia and re-oxygenation of the joint
Taking into consideration that cartilage does not contain 
any teleneurons, regulation of chondrocytes should be of 
chemical nature. In the relaxed state – for example, at night 
– chondrocytes experience a decreased oxygen supply (a 
status termed “hypoxia”). However when the status changes 
to an enhanced mobility in the morning, joint SF receives 
elevated supply of oxygen (a situation termed “re-oxygen-
ation”). Such increased content of oxygen can be, however, 
deleterious for the homeostasis of the chondrocytes – the 
cells that in adults lack mitotic activity.
As “normal” SF contains no hyaluronidase activity, it 
has been inferred that oxygen-derived reactive species/
metabolites are involved in a self-perpetuating process of 
hyaluronan catabolism within the joint (Grootveld et al., 
1991). This process has been considered responsible for the 
short – about twelve hours – half-life of native HA macro-
molecules in SF.
To understand how to keep a radical reaction active/self-
perpetuating, its propagation stage should first be analyzed. 
Let us assume that a peroxyl-type macromolecular radical 
(AOO•) exists within SF. Taking into account the relatively 
high reactivity/affinity of the unpaired electron on the oxy-
gen, the following particular reaction step can be assumed
AOO• + HA → AOOH + A•   (9)
where HA abbreviates the hyaluronan, in which H stands 
for a hydrogen atom – the abstraction of which by the 
AOO• radical leads to the formation of an A• macroradical. 
In the case when A• is a carbon macroradical, it is especially 
this reactant, which traps the excess of dioxygen molecule(s) 
according to the reaction
A• + O2 → AOO•   (10)
Hence, simply by combining the two reactions 9 and 10, 
the net reaction 
HA + O2 → AOOH net  reaction
corroborates the statement that one particular function of 
(a high-molar-mass) HA is to trap the oxygen excess during 
the stage of joint re-oxygenation.
Participation of biogenic transition metals 
in physiologic catabolism of hyaluronan 
Analogously to the decomposition of lipid hydroperoxides 
(reactions 6 and 8) caused by a transition metal, similar 
reactions could be suggested for decomposition of the 
cumulating AOOH hydroperoxides
AOOH + Fe(II) → AO• + HO– + Fe(III)   (11)
AOOH + Fe(III) → AOO• + Fe(II) + H+  ( 12) 
As evident, while the reactant/”propagator” entering into 
reaction 9 is regenerated/recycled by reaction 12, reaction 
11 produces an alkoxyl macroradical. The ratio between 
the generated AOO• to AO• radicals is however governed 
by the present iron, or more precisely by the ratio of Fe(III) 
to Fe(II). However, in the case of a sufficiently high level 
of ascorbate, an efficient reductant of ferric cations, actual 
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Figure 1. Hyaluronan – the acid form.235
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concentration of Fe(II) ions exceeds that of Fe(III), and thus 
AO• radicals should prevail. These radicals could, similarly 
to the AOO• ones, propagate the radical chain reaction as 
follows
AO• + HA → AOH + A•   (13)
however assuming the quenching of AO• radicals by ascor-
bate, the products would now contain “oxidized” hyaluronan 
macromolecules plus DHA and/or its hydrolyzates.
Higher reactivity of AO• radicals with ascorbate com-
pared to that of the AOO• radicals, closely correlates with 
the about 1,000-times higher value of the rate-constant (k) 
in the case of reduction of alkoxyl radicals. For example, the 
k values estimated for the reactions between ascorbate and 
a tocopheryl (T) radical TO• or peroxyl-type radical TOO•, 
equal 1.6×109 or (1–2)×106 M–1s–1, respectively and, hence, 
the half-life of the alkoxyl radical is much shorter than that 
of peroxyl – microseconds vs. seconds. Analogously, the 
redox potential of the pair RO•,H+/ROH = 1.6 V exceeds 
significantly that of ROO•,H+/ROOH = 1.0 V.
Yet, concerning the radical reactions of carbohydrate 
polymers, the strand scission of AO• as well as of AOO• 
(intermediate) macroradicals represents a very plausible 
pathway, by which polymer fragments of shorter molecular 
size shall be generated (cf. Scheme 2) (see also Refs. Rychlý 
et al., 2006; Šoltés et al., 2006; Stern et al., 2007). 
Along with the above described hyaluronan fragmenta-
tion reactions, the radical attack on the d-glucuronate/d-
glucuronic acid and N-acetyl-d-glucosamine moieties can 
also lead to the “opening” of rings without breaking the 
polymer chain (Kogan et al., 2007; 2008; Hawkins and 
Davies, 1996).
Actors of physiologic catabolism of 
hyaluronan in the synovial fl  uid
The concentration of ascorbate in SF of healthy subjects 
reaches the values close to those established in blood serum, 
i.e. 40–140 μM (Wong et al., 1981). The contents of transi-
tion metals in both body fluids are listed in Table 3.
As evident from the data listed in Table 3, iron and cop-
per are the two prevailing redox active transition metals in 
SF. It should be, however, pointed out that the respective 
levels of ca. 5.2 and 4.3 μM do not represent those, which 
are (freely) disposable to catalyze the oxidative catabolism of 
hyaluronan within SF. As has been reported, the availability 
of iron to stimulate in vivo generation of •OH radicals is very 
limited, since concentrations of bleomycin-detectable, i.e. 
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Scheme 2. AO• strand scission may be due to β-cleavage of the radical formed at, e.g. C(1) on the ring of D-glucuronate/D-glucuronic acid.
Table 3. Contents of transition metals in blood serum of healthy human 
volunteers and in post mortem collected SF from subjects without evi-
dence of connective tissue disease
Element
Mean concentration 
in blood serum 
[μg/100 mL]a
Mean concentration 
in synovial fluid 
[μg/100 g]a
Manganese 2.4 (0.44)b 2.4 (0.44)
Iron 131.7 (23.6) 29.0 (5.19)
Nickel 4.1 (0.70) 1.2 (0.20)
Copper 97.0 (15.3) 27.5 (4.33)
Zinc 115.4 (17.7) 17.6 (2.69)
Molybdenum 3.4 (0.35) 1.0 (0.10)
a Reported by Niedermeier and Griggs (1971).
b Data in parentheses are the values in μM calculated in assumption 
that 100 g of SF has a volume of 100 mL. 236
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“free” iron, are rarely larger than 3 μM in human samples 
(Halliwell and Gutteridge, 1990).
Figure 2 illustrates the viscosity-time profiles of a model 
situation, where – along with 100 μM ascorbate – a single 
transition metal is involved (Valachova et al., 2009). As 
evident, a significant reduction of the solution dynamic 
viscosity (η), corresponding to the degradation of the high-
molar-mass HA sample, clearly indicates a concentration-
dependent manner for each metal (cf. left and central 
panels in Figure 2). As can be seen, the character of the time 
dependence of η value upon the addition of FeCl2 (5.0 μM) 
can be described as a gradual monotonous decline, while the 
addition of CuCl2 (5.0 μM) resulted in a literally “dramatic” 
drop of η value within a short time interval (30 min), after 
which the decrease of the solution dynamic viscosity contin-
ued, yet at a much lower rate. A possible explanation of this 
dissimilarity lies most probably in different reaction kinetics 
of the processes leading to generation of oxygen-derived 
reactive species in the system ascorbate plus Cu(II) and in 
that comprising ascorbate plus Fe(II), i.e. Weissberger’s and 
Udenfriend’s oxidative systems.
A similar drop of η value and two-phase reaction kinetics 
are identifiable upon the addition of even a minute (0.1 μM) 
amount of CuCl2 (see Figure 2, central panel), however when 
Cu(II) addition preceded that of ascorbate (right panel), the 
decline of the solution viscosity was much less marked. A 
plausible explanation of this observation is that a delay in 
ascorbate addition (9 min) allowed the Cu(II) ions to reach 
the “binding sites” within the HA macromolecule. The 
domain of the coordinate-bound copper formed in such a 
way seems to be “hindered” and hence less accessible for a 
direct complexation/interaction with the ascorbate anion, a 
condition that is required for formation of the Weissberger’s 
oxidative complex. As postulated, hyaluronate binding sites 
indicate a (weak) selectivity not only toward copper but also 
to (isoelectronic) zinc cations (Magnani et al., 1999). On the 
contrary, manganous and presumably also (isoelectronic) Fe 
cations form simple hyaluronate salts with d-glucuronate 
moieties (Pirc et al., 2004). Thus, the four transition metal 
elements, namely iron, copper, manganese, and zinc, may by 
their presence/absence create a variety of conditions under 
which HA oxidative degradation proceeds.
There exists, however, a marked difference between 
degradation of hyaluronan in vitro/in situ and its in vivo 
catabolism. Under physiological conditions, the SF viscosity 
does not indicate any changes since the content of “native” 
hyaluronan remains constant due to permanent de novo 
production of megadalton HA macromolecules by (stimu-
lated) synoviocytes. Thus, the self-perpetuating oxidative 
(non-enzymatic) HA catabolism in SF represents a rather 
delicate and properly balanced mechanism that presumably 
plays significant role in regulating the physiological – nor-
moxygen – homeostasis for chondrocytes. At the same time, 
the polymer fragments formed, which are removed by drain-
age pathways from the joint, serve most likely as chemical 
messengers/feedback molecules used for adjustment of the 
optimum mode of functioning of the synovial membrane 
and of the HA-producing cells, synoviocytes, localized 
within. In the other words, during physiologic joint func-
tioning, the hyaluronan in SF plays the role of a “scavenger 
antioxidant”, whereas the produced polymer fragments can 
subsequently serve as messengers mediating information on 
the changes occurring in the homeostasis of the joint.
High “protective/scavenging efficiency” of hyaluronan 
against the action of e.g. •OH radicals has been earlier 
pointed out by some authors (Myint et al., 1987; Presti and 
Scott, 1994). Presti and Scott (1994) described that high-
molar-mass hyaluronan (1218 kDa) was much more effec-
tive than the lower-molar-mass (668 and 176 kDa) HAs in 
scavenging •OH radicals generated by a Fenton-type system 
comprising glucose and glucose oxidase plus Fe2+-EDTA 
chelate.
Pathophysiologic catabolism of 
hyaluronan in synovial fl  uid
Despite their exceedingly simple primary structure, the HA 
macromolecules have extraordinarily wide-ranging and 
often opposing biological functions. As recently reported 
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Figure 2. Time dependences of dynamic viscosity of hyaluronan (P9710-2A) sample solutions (2.5 mg/mL).
Left panel: Solutions of the HA sample with addition of 100 μM ascorbic acid immediately followed by admixing 0.5 or 5.0 μM of FeCl2.
Middle panel: Solutions of the HA sample with addition of 100 μM ascorbic acid immediately followed by admixing 0.1 or 5.0 μM of CuCl2.
Right panel: The curve represents an assay, in which 0.1 μM of CuCl2 was added to the HA sample solution 9 minutes before admixing 100 μM 
ascorbic acid (for details see Šoltés et al., 2007).237
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by Stern et al., the unadorned HA polymer functions size-
specifically and its fragments constitute a very information-
rich system (Stern et al., 2006). While “space-filling” mega-
dalton hyaluronans, synthesized by HA synthases (HAS1 
and HAS2) (Itano et al., 1999; Weigel and DeAngelis, 2007), 
are immunosuppressive and anti-angiogenic (McBride and 
Bard, 1979; Delmage et al., 1986; Feinberg and Beebe, 1983), 
the intermediate-sized HA-polymer fragments are inflam-
matory, immunostimulatory, and highly angiogenic (Noble, 
2002; West et al., 1985; Jiang et al., 2007).
There are two distinct modes to cleave in vivo the 
extended native HA chains: the enzymatic, involving 
participation of the hyaluronidases (e.g. Hyal-2) and the 
chemical one, involving oxygen-derived reactive species 
(Stern et al., 2007). Yet, due to the fact that SF is lacking 
any hyaluronidases, it is reasonable to assume that it is the 
latter mechanism, which might be involved also during 
HA catabolism in the inflamed joint. As can be seen from 
Figure 2, any transition metal, i.e. iron or copper, can play 
an active role in the oxidative HA catabolism. However, 
the increase in Cu(II) concentration within the joint (and 
particularly in SF) could lead to a really very rapid degrada-
tion of the native HA macromolecules.
Figure 3 exemplifies the impact of two different 
oxidative systems comprising Cu(II) ions. As evident, a 
megadalton HA sample (Mw = 1.2 MDa) degrades in situ to 
intermediate-sized polymer fragments, which mean molar 
masses are reduced by one or even two orders of magni-
tude. Interestingly, the unimodal and relatively narrow 
molar-mass distribution (MMD) of the megadalton HA 
sample (Mw/Mn = 1.8) remains retained even upon cleaving 
the polymer (compare the three MMD curves in Figure 3).
Some differences should be, however, pointed out 
between the processes taking place in a joint (or locally 
within SF) and in a well-stirred reaction mixture under in 
situ conditions. In the bloodstream, the copper atoms are 
carried by ceruloplasmin, belonging to the so-called “acute 
phase proteins”, which concentration increases markedly 
under certain circumstances (Shukla et al., 2006). Higher 
ceruloplasmin concentration in the blood plasma would 
mean a larger amount of copper that crosses the synovial 
membran  e  . Yet, due to the SF gel-like consistency, the 
copper ions entering into this specific environment should 
start their “dramatic” oxidative action in the vicinity of 
the synovial membrane. How efficiently the chemically 
generated •OH radicals are “scavenged” within this micro-
environment by the locally disposable albumin as well as 
by the HA polymer fragments of lower molecular size, 
remains questionable. The oxidative process may escape 
the control mechanisms and damage/disrupt the synovial 
membrane. Moreover, the intermediate-sized HA-polymer 
fragments generated within this microenvironment could 
participate in the activation of “defender” cells. They may 
further aggrandize the inflammation state of the injured 
tissue(s) because the HA-polymer fragments can augment 
in turn inflammatory responses. As reported by Jiang et 
al., the HA fragments in the e.g. 2×105 Da range induce in 
macrophages the expression of a number of inflammatory 
mediators, including chemokines, cytokines, growth fac-
tors, proteases, and nitric oxide (Jiang et al., 2007). In this 
way, the oxidants generated by activated defender cells may 
enlarge the damage within the involved joint tissues such as 
the synovial membrane.
Moreover, it appears that reactive oxygen species disrupt 
copper binding to ceruloplasmin, thereby releasing “free” 
copper ions, which in turn may promote oxidative pathol-
ogy (Shukla et al., 2006). The damage can be manifested 
by visually localizable cardinal symptoms of inflammation 
– color, dolor, rubor, tumor, and functiolaesa. Yet, although 
less distinct, repeated (micro-acute) inflammatory injures 
may lead to a disastrous outcome – e.g. an autoimmune 
disease – such as rheumatoid arthritis. 
The mutual substitution of (isoelectronic) transition 
metals, their versatile coordination chemistry and redox 
properties, along with changes in their compartmentaliza-
tion and binding to the designated tissue/cell constituents 
may reflect certain non-specific physiologic responses of 
the organism to pathologic stimuli (Valko et al., 2005). 
Rheumatoid arthritis can be classified as one of the diseases 
of particular interest in this respect. In the synovial fluid 
from patients with rheumatoid arthritis compared to SF 
from normal/healthy subjects, the mean concentration of 
copper is increased by a factor of three and that of iron and 
zinc by 2 and 3.5, respectively (Niedermeier and Griggs, 
1971). 
There are several chronic (inflammatory) conditions, 
in which “abnormalities” in the metabolism of trace/
transition metal(s) are at present in the focus of biomedical 
research. The diseases – such as the autoimmune rheu-
matoid arthritis, the neurodegenerative Alzheimer’s and 
Parkinson’s diseases – are classified as socially debilitating. 
Considering the fact of permanently extending mean life-
span of the human population, these diseases create serious 
ethical/societal issues, like that of euthanasia. 
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Figure 3. Comparison of MMD of the megadalton HA sample and 
those degraded in situ by oxygen-derived reactive species (cf. also 
Figure 2 and Ref. Šoltés et al., 2007).238
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